Literature DB >> 2523364

Morphea after bromocriptine therapy.

B Leshin1, W W Piette, R M Caplan.   

Abstract

A 57-year-old man developed morphea while taking bromocriptine. This drug is a semisynthetic ergot alkaloid, one of a class of drugs that is associated with fibrotic disorders. Other agents known for such association are serotonin (5-hydroxytryptamine) and beta-adrenergic blockers. A common pathogenesis to link these agents to fibrosis remains uncertain.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2523364     DOI: 10.1111/j.1365-4362.1989.tb02457.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  1 in total

1.  New-onset systemic sclerosis and scleroderma renal crisis under docetaxel.

Authors:  Véronique Debien; Arthur Petitdemange; Dorothée Bazin; Carole Ederle; Benoit Nespola; Hamid Merdji; Jérome Olagne; Thierry Martin; Aurélien Guffroy; Carole Pflumio
Journal:  J Scleroderma Relat Disord       Date:  2021-04-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.